Single-dose Prophylactic INdomethacin in Extremely Preterm Infants

NCT06572917 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

500

Enrollment

OTHER

Sponsor class

Conditions

Extreme Prematurity
Intraventricular Hemorrhage
Morbidity;Newborn

Interventions

DRUG: Indomethacin
DRUG: Placebo

Sponsor

University of British Columbia